Since the 1980s, TMS has been used to study nerve fibers that carry information about movements from the brain to the spinal cord, and on to the muscles. In the late 1990s, physicians began to explore the therapeutic potential of TMS for a variety of diseases, with depression being most studied to date. Since then, more than 20 randomized controlled trial studying TMS as a treatment for depression have been published by investigators throughout the world.
NeuroStar TMS (transcranial magnetic stimulation) Therapy was FDA-cleared in October 2008 for patients suffering from depression. Using pulsed magnetic fields, TMS therapy stimulates the part of the brain thought to control mood regulation. TMS Therapy is a short outpatient procedure, performed in your psychiatrist's office under his supervision while you remain awake and alert. The typical initial course of treatment is about 37 minutes spread over 4-6 weeks.
The NeuroStar® TMS Therapy system, developed by Neuronetics, is the first and only non-systematic and non-invasive depression treatment cleared by the Food and Drug Administration for patients who have not benefited from prior antidepressant treatment.
NeuroStar® TMS Therapy is:
Prasad V. Reddy MD